Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GALR3 | O60755 | 2/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.38 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphocholine SCHEMBL15862263 | 0.89 | CHRM5 (0.42) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 | |
| Phosphocholine SCHEMBL28232275 | 0.89 | CHRM5 (0.42) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 | |
| Phosphocholine SCHEMBL12979922 | 0.88 | SMN1; SMN2 (0.45) | CHRM5CHRM1CHRM3SMN1; SMN2CHRM2 | |
| Phosphocholine SCHEMBL1949342 | 0.86 | TSHR (0.51) | SMN1; SMN2THRBMAPTTSHRLMNA | |
| SCHEMBL6462016 | 0.84 | THRB (0.45) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL24982077 | 0.84 | THRB (0.40) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 | |
| Phosphoric Acid SCHEMBL9619842 | 0.84 | CHRM5 (0.53) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 | |
| Phosphocholine SCHEMBL2456735 | 0.82 | SMN1; SMN2 (0.42) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 | |
| Phosphoric Acid SCHEMBL7192564 | 0.82 | CHRM5 (0.55) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL20401677 | 0.81 | SMN1; SMN2 (0.49) | GALR3CHRM5CHRM1CHRM3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180105665-A1 | SURFACE MODIFIED POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. | 2018-04-19 | — | — | US | claimed |
| US-11578205-B2 | Antimicrobial, non-thrombogenic polymer composition | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-02-14 | — | — | US | disclosed |
| EP-3207128-B1 | BUTYRYLCHOLINESTERASE ZWITTERIONIC POLYMER CONJUGATES | KODIAK SCIENCES INC (US) | 2022-07-27 | — | — | EP | disclosed |
| CN-107787230-B | Surface-modified polymer composition | 路博润先进材料公司 | 2022-01-21 | — | — | CN | disclosed |
| EP-3361868-B1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2021-12-15 | — | — | EP | disclosed |
| US-20210277231-A1 | Antimicrobial, Non-Thrombogenic Polymer Composition | LUBRIZOL ADVANCED MAT INC (US) | 2021-09-09 | — | — | US | disclosed |
| US-11071771-B2 | Butyrylcholinesterase zwitterionic polymer conjugates | KODIAK SCIENCES INC. (US) | 2021-07-27 | — | — | US | disclosed |
| US-10829606-B2 | Surface modified polymer compositions | LUBRIZOL ADVANCED MATERIALS, INC. | 2020-11-10 | — | — | US | disclosed |
| US-10827757-B2 | Biocidally active polymer compositions | LUBRIZOL ADVANCED MATERIALS, INC. | 2020-11-10 | — | — | US | disclosed |
| US-20190255155-A1 | BUTYRYLCHOLINESTERASE ZWITTERIONIC POLYMER CONJUGATES | OLIGASIS, LLC | 2019-08-22 | — | — | US | disclosed |
| WO-2017066242-A1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2017-04-20 | — | — | WO | disclosed |
| WO-2016172460-A1 | SURFACE MODIFIED POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2016-10-27 | — | — | WO | disclosed |
| US-20160184445-A1 | BUTYRYLCHOLINESTERASE ZWITTERIONIC POLYMER CONJUGATES | OLIGASIS, LLC | 2016-06-30 | — | — | US | disclosed |
| WO-2016061562-A2 | BUTYRYLCHOLINESTERASE ZWITTERIONIC POLYMER CONJUGATES | KODIAK SCIENCES INC. (US) | 2016-04-21 | — | — | WO | disclosed |
| US-9006305-B2 | Biocompatible material | VERTELLUS SPECIALTIES INC. (US) | 2015-04-14 | — | — | US | disclosed |
| US-8980956-B2 | Methods for producing biocompatible materials | VERTELLUS SPECIALITIES INC. (US) | 2015-03-17 | — | — | US | disclosed |
| EP-2751153-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | Vertellus Specialties Inc. (US) | 2014-07-09 | — | — | EP | disclosed |
| WO-2013033553-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VERTELLUS SPECIALTIES INC. (US) | 2013-03-07 | — | — | WO | disclosed |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
| US-20130059970-A1 | BIOCOMPATIBLE MATERIAL | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184445-A1 | BUTYRYLCHOLINESTERASE ZWITTERIONIC POLYMER CONJUGATES | BCHE, ACHE, FCER2 | GALR3 1277/4885CHRM5 250/4885CHRM1 411/4885 |
| US-11071771-B2 | Butyrylcholinesterase zwitterionic polymer conjugates | BCHE, ACHE, FCER2 | GALR3 1277/4885CHRM5 250/4885CHRM1 411/4885 |
| US-20130059970-A1 | BIOCOMPATIBLE MATERIAL | VCL, ITGAM, MACF1 | GALR3 3997/4885CHRM5 3319/4885CHRM1 1372/4885 |
| US-20190255155-A1 | BUTYRYLCHOLINESTERASE ZWITTERIONIC POLYMER CONJUGATES | BCHE, ACHE, FCER2 | GALR3 1277/4885CHRM5 250/4885CHRM1 411/4885 |
| US-10827757-B2 | Biocidally active polymer compositions | PUF60, FGB, PARG | GALR3 2892/4885CHRM5 4779/4885CHRM1 4755/4885 |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VCL, ECPAS, MACF1 | GALR3 3817/4885CHRM5 1752/4885CHRM1 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.